- Home
- FIVE vs PODD Comparison
FIVE vs PODD Comparison
Compare FIVE & PODD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FIVE | PODD |
|---|---|---|
| Founded | 2002 | 2000 |
| Country | United States | United States |
| Employees | N/A | 5400 |
| Industry | Department/Specialty Retail Stores | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.6B | 10.2B |
| IPO Year | 2012 | 2007 |
Fundamental Metrics
Financial Performance| Metric | FIVE | PODD |
|---|---|---|
| Price | $252.20 | $147.48 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 20 | 21 |
| Target Price | $236.00 | ★ $341.48 |
| AVG Volume (30 Days) | 1.0M | ★ 1.6M |
| Earning Date | 06-03-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 40.65 | N/A |
| EPS | ★ 6.20 | 2.67 |
| Revenue | ★ $4,764,147,000.00 | $2,708,100,000.00 |
| Revenue This Year | $14.44 | $24.55 |
| Revenue Next Year | $9.37 | $19.18 |
| P/E Ratio | $109.37 | ★ $56.08 |
| Revenue Growth | 22.90 | ★ 30.73 |
| 52 Week Low | $138.18 | $126.40 |
| 52 Week High | $263.88 | $354.88 |
Technical Indicators
Market Signals| Indicator | FIVE | PODD |
|---|---|---|
| Relative Strength Index (RSI) | 54.16 | 50.87 |
| Support Level | $234.55 | $139.67 |
| Resistance Level | $250.32 | $155.17 |
| Average True Range (ATR) | 9.72 | 5.28 |
| MACD | -2.21 | 0.94 |
| Stochastic Oscillator | 24.39 | 67.83 |
Price Performance
Historical ComparisonAbout FIVE Five Below Inc.
Five Below Inc is a specialty value retailer offering a broad range of trend-right, high-quality products loved by the kid and the kid in all of customers. The Company's edited assortment of products includes select brands and licensed merchandise. The Company also sells its merchandise on the internet, through the Company's e-commerce website and mobile app, offering home delivery and the option to buy online and pick up in store. Additionally, the Company sells merchandise through on-demand third-party delivery services to enable its customers to shop online and receive convenient delivery. It derives revenue from sales of the Company's merchandise to customers.
About PODD Insulet Corporation
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, more than 600,000 insulin-dependent diabetic patients are using it worldwide.